---

A review of the pharmacological and bioactive compounds of syzygium cumini

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Kiran P. Gaikwad*, Chanchal S. Chandak, Jaya P. Ambhore, Mahesh B. Narkhede, Ashwini A

Volume : 9, Issue : 3, Year : 2024

Article Page : 166-176

https://doi.org/10.18231/j.ijcaap.2024.024

Suggest article by email

Get Permission

Abstract

The field of herbal medicine has grown rapidly in the past several years, and due to their natural origins and lower side effects, these medications are becoming more and more well-liked in both developed and developing nations. The plant known as jamun, Syzygium cumini (also called Eugenia jambolana, Syzygium jambolana, Eugenia cumini, and Syzygium jambos), is a great source of bioactive substances such flavonoids, polyphenols, antioxidants, iron, and vitamin C. The Myrtaceae family includes the essential medicinal plant known as the jamun tree, which is a tropical evergreen blooming plant that has long been utilized in Indian and other traditional remedies around the world. The majority of jamun's cultivation occurs in Asian nations like Bangladesh, Sri Lanka, India, and Pakistan. It has been used to treat a wide range of illnesses and physiological disorders since the days of ancient medicine. In terms of medicine, the fruit is said to have properties that help with hyperlipidemia, hypertension, obesity, antidiarrheal, antiallergic, antiarthritic, antimicrobial, anti-inflammatory, antifertility, antipyretic, antiplaque, radioprotective, neuropsychopharmacological, and antiulcer, hepatoprotective, antiallergic, antiarthritic, antioxidant, and various metabolic problems. This review examines the various dietary applications as well as the nutritional, phytochemical, and medicinal possibilities.

Keywords: Syzygium cumini, Antimicrobial, Anti­inflammatory

How to cite : Gaikwad K P, Chandak C S, Ambhore J P, Narkhede M B, Ashwini A, A review of the pharmacological and bioactive compounds of syzygium cumini. IP Int J Compr Adv Pharmacol 2024;9(3):166-176

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.